Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Alcohol septal ablation in patients with severe septal hypertrophy

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Socioeconomic disparities in prehospital factors and survival after out-of-hospital cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Temporal changes in the incidence of infective endocarditis in Denmark 1997-2017: A nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long QT syndrome type 1 and 2 patients respond differently to arrhythmic triggers: The TriQarr in vivo study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Josef Veselka
  • Morten Jensen
  • Max Liebregts
  • Robert M Cooper
  • Jaroslav Januska
  • Maksim Kashtanov
  • Maciej Dabrowski
  • Peter Riis Hansen
  • Hubert Seggewiss
  • Eva Hansvenclova
  • Henning Bundgaard
  • Jurrien Ten Berg
  • Rodney Hilton Stables
  • Lothar Faber
View graph of relations

OBJECTIVE: The current guidelines suggest alcohol septal ablation (ASA) is less effective in hypertrophic obstructive cardiomyopathy (HOCM) patients with severe left ventricular hypertrophy, despite acknowledging that systematic data are lacking. Therefore, we analysed patients in the Euro-ASA registry to test this statement.

METHODS: We compared the short-term and long-term outcomes of patients with basal interventricular septum (IVS) thickness <30 mm Hg to those with ≥30 mm Hg treated using ASA in nine European centres.

RESULTS: A total of 1519 patients (57±14 years, 49% women) with symptomatic HOCM were treated, including 67 (4.4%) patients with IVS thickness ≥30 mm. The occurrence of short-term major adverse events were similar in both groups. The mean follow-up was 5.4±4.3 years and 5.1±4.1 years, and the all-cause mortality rate was 2.57 and 2.94 deaths per 100 person-years of follow-up in the IVS <30 mm group and the IVS ≥30 mm group (p=0.047), respectively. There were no differences in dyspnoea (New York Heart Association class III/IV 12% vs 16%), residual left ventricular outflow tract gradient (16±20 vs 16±16 mm Hg) and repeated septal reduction procedures (12% vs 18%) in the IVS <30 mm group and IVS ≥30 mm group, respectively (p=NS for all).

CONCLUSIONS: The short-term results and the long-term relief of dyspnoea, residual left ventricular outflow obstruction and occurrence of repeated septal reduction procedures in patients with basal IVS ≥30 mm is similar to those with IVS <30mm. However, long-term all-cause and cardiac mortality rates are worse in the ≥30 mm group.

Original languageEnglish
JournalHeart (British Cardiac Society)
Volume106
Issue number6
Pages (from-to)462-466
Number of pages5
ISSN1355-6037
DOIs
Publication statusPublished - Mar 2020

Bibliographical note

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

    Research areas

  • alcohol septal ablation, hypertrophic cardiomyopathy, outflow gradient, prognosis, survival

ID: 58015341